Abnormal medial thalamic metabolism in patients with idiopathic restless legs syndrome

Brain

Volumn 135, Issue 12, 2012, Pages 3712-3720

  Rizzo, Giovanni ^a,b   Tonon, Caterina ^a   Testa, Claudia ^a   Manners, David ^a   Vetrugno, Roberto ^a   Pizza, Fabio ^a,b   Marconi, Sara ^a,b   Malucelli, Emil ^a   Provini, Federica ^a,b   Plazzi, Giuseppe ^a,b   Montagna, Pasquale ^a   Lodi, Raffaele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b IRCCS ISTITUTO DELLE SCIENZE NEUROLOGICHE DI BOLOGNA   (Italy)

Author keywords

central pain; DTI; MRS; restless legs syndrome; VBM

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN METABOLISM; BRAIN PARENCHYMA; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; FEMALE; FRACTIONAL ANISOTROPY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMAGE ANALYSIS; MALE; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RESTLESS LEGS SYNDROME; THALAMUS; VOXEL BASED MORPHOMETRY;

EID: 84871820963     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws266     Document Type: Article

References (59)

1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4: 101-19.
2. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 2005; 9: 463-84.
3. Arnold DL, Matthews PM, Francis G, Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn Reson Med 1990; 14: 154-9.
4. Astrakas LG, Konitsiotis S, Margariti P, Tsouli S, Tzarouhi L, Argyropoulou MI. T2 relaxometry and fMRI of the brain in late-onset restless legs syndrome. Neurology 2008; 71: 911-6.
5. Bachmann CG, Rolke R, Scheidt U, Stadelmann C, Sommer M, Pavlakovic G, et al. Thermal hypoaesthesia differentiates secondary restless legs syndrome associated with small fibre neuropathy from primary restless legs syndrome. Brain 2010; 133: 762-70.
6. Briellmann RS, Wellard RM, Jackson GD. Seizure associated abnormalities in epilepsy: evidence from MR imaging. Epilepsia 2005; 46: 760-6.
7. Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993; 15: 289-98.
8. Bucher SF, Seelos KC, Oertel WH, Reiser M, Trenkwalder C. Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol 1997; 41: 639-45.
9. Celle S, Roche F, Kerleroux J, Thomas-Anterion C, Laurent B, Rouch I, et al. Prevalence and clinical correlates of restless legs syndrome in an elderly French population: the synapse study. J Gerontol A Biol Sci Med Sci 2010a; 65: 167-73.
10. Celle S, Roche F, Peyron R, Faillenot I, Laurent B, Pichot V, et al. Lack of specific gray matter alterations in restless legs syndrome in elderly subjects. J Neurol 2010b; 257: 344-8.
11. Cervenka S, Pålhagen SE, Comley RA, Panagiotidis G, Cselényi Z, Matthews JC, et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain 2006; 129: 2017-28.
12. Cho SJ, Hong JP, Hahm BJ, Jeon HJ, Chang SM, Cho MJ, et al. Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders. Sleep 2009; 32: 1069-76.
13. Clark L, Chamberlain SR, Sahakian BJ. Neurocognitive mechanisms in depression: implications for treatment. Annu Rev Neurosci 2009; 32: 57-74.
14. Clemens S, Rye D, Hochman S. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 2006; 67: 125-30.
15. Comley RA, Cervenka S, Palhagen SE, Panagiotidis G, Matthews JC, Lai RY, et al. A comparison of gray matter density in restless legs syndrome patients and matched controls using voxel-based morphom-etry. J Neuroimaging 2012; 22: 28-32.
16. Dautry C, Vaufrey F, Brouillet E, Bizat N, Henry PG, Conde F, et al. Early Nacetylaspartate depletion is a marker ofneuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. J Cereb Blood Flow Metab 2000; 20: 789-99.
17. De Witte L, Brouns R, Kavadias D, Engelborghs S, De Deyn PP, Mariën P. Cognitive, affective and behavioural disturbances following vascular thalamic lesions: a review. Cortex 2011; 47: 273-319.
18. Demougeot C, Garnier P, Mossiat C, Bertrand N, Giroud M, Beley A, et al. N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J Neurochem 2001; 77: 408-15.
19. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 2008; 213: 93-118.
20. Edwards RR, Quartana PJ, Allen RP, Greenbaum S, Earley CJ, Smith MT. Alterations in pain responses in treated and untreated patients with restless legs syndrome: associations with sleep disruption. Sleep Med 2011; 12: 603-9.
21. Etgen T, Draganski B, Ilg C, Schröder M, Geisler P, Hajak G, et al. Bilateral thalamic gray matter changes in patients with restless legs syndrome. Neuroimage 2005; 24: 1242-7.
22. Freeman A, Ciliax B, Bakay R, Daley J, Miller RD, Keating G, et al. Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models. Ann Neurol 2001; 50: 321-9.
23. Fulda S, Beitinger ME, Reppermund S, Winkelmann J, Wetter TC. Short-term attention and verbal fluency is decreased in restless legs syndrome patients. Mov Disord 2010; 25: 2641-8.
24. Gamaldo CE, Benbrook AR, Allen RP, Oguntimein O, Earley CJ. A further evaluation of the cognitive deficits associated with restless legs syndrome (RLS). Sleep Med 2008; 9: 500-5.
25. Gasparovic C, Song T, Devier D, Bockholt HJ, Caprihan A, Mullins PG, et al. Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med 2006; 55: 1219-26.
26. Haselgrove JC, Moore Jr. Correction for distortion of echo-planar images used to calculate the apparent diffusion coefficient. Magn Reson Med 1996; 36: 960-4.
27. Hornyak M. Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management. CNS Drugs 2010; 24: 89-98.
28. Hornyak M, Ahrendts JC, Spiegelhalder K, Riemann D, Voderholzer U, Feige B, et al. Voxel-based morphometry in unmedicated patients with restless legs syndrome. Sleep Med 2007; 9: 22-6.
29. Hornyak M, Sohr M, Busse M. 04 and 615 Study Groups. Evaluation of painful sensory symptoms in restless legs syndrome: experience from two clinical trials. Sleep Med 2011; 12: 186-9.
30. Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002; 17: 825-41.
31. Karroum EG, Golmard JL, Leu-Semenescu S, Arnulf I. Sensations in restless legs syndrome. Sleep Med 2012; 13: 402-8.
32. Lodi R, Parchi P, Tonon C, Manners D, Capellari S, Strammiello R, et al. Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. Brain 2009; 132: 2669-79.
33. Millan MJ. Descending control of pain. Prog Neurobiol 2002; 66: 355-474.
34. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 2007; 81: 89-131.
35. Montagna P. Fatal familial insomnia and the role of the thalamus in sleep regulation. Handb Clin Neurol 2011; 99: 981-96.
36. Pearson VE, Allen RP, Dean T, Gamaldo CE, Lesage SR, Earley CJ. Cognitive deficits associated with restless legs syndrome (RLS). Sleep Med 2006; 7: 25-30.
37. Price DD. Psychological and neural mechanisms of the affective dimension of pain. Science 2000; 288: 1769-72.
38. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-9.
39. Rizzo G, Manners D, Vetrugno R, Tonon C, Malucelli E, Plazzi G, et al. Combined brain voxel-based morphometry and diffusion tensor imaging study in idiopathic restless legs syndrome patients. Eur J Neurol 2012; 19: 1045-9.
40. Rye DB. Parkinson's disease and RLS: the dopaminergic bridge. Sleep Med 2004; 5: 317-28.
41. San Pedro EC, Mountz JM, Mountz JD, Liu HG, Katholi CR, Deutsch G. Familial painful restless legs syndrome correlates with pain dependent variation of blood flow to the caudate, thalamus, and anterior cingu-lated gyrus. J Rheumatol 1998; 25: 2270-5.
42. Schattschneider J, Bode A, Wasner G, Binder A, Deuschl G, Baron R. Idiopathic restless legs syndrome: abnormalities in central somatosen-sory processing. J Neurol 2004; 251: 977-82.
43. Signoretti S, Marmarou A, Tavazzi B, Lazzarino G, Beaumont A, Vagnozzi R. N-Acetylaspartate reduction as a measure of injury severity and mitochondrial dysfunction following diffuse traumatic brain injury. J Neurotrauma 2001; 18: 977-91.
44. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp 2002; 17: 143-55.
45. Smith MT, Edwards RR, McCann UD, Haythornthwaite JA. The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep 2007; 30: 494-505.
46. Stiasny-Kolster K, Magerl W, Oertel WH, Moller JC, Treede RD. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain 2004; 127: 773-82.
47. Tekin S, Cummings JL. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 2002; 53: 647-54.
48. Treede RD, Kenshalo DR, Gracely RH, Jones AK. The cortical representation of pain. Pain 1999; 79: 105-11.
49. Trenkwalder C, Hening WA, Montagna P, Oertel WH, Allen RP, Walters AS, et al. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord 2008; 23: 2267-302.
50. Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol 2005; 4: 465-75.
51. Tyvaert L, Houdayer E, Devanne H, Bourriez JL, Derambure P, Monaca C. Cortical involvement in the sensory and motor symptoms of primary restless legs syndrome. Sleep Med 2009; 10: 1090-6.
52. Unrath A, Juengling FD, Schork M, Kassubek J. Cortical grey matter alterations in idiopathic restless legs syndrome: an optimized voxel-based morphometry study. Mov Disord 2007; 22: 1751-6.
53. Unrath A, Müller HP, Ludolph AC, Riecker A, Kassubek J. Cerebral white matter alterations in idiopathic restless legs syndrome, as measured by diffusion tensor imaging. Mov Disord 2008; 23: 1250-5.
54. von Spiczak S, Whone AL, Hammers A, Asselin MC, Turkheimer F, Tings T, et al. The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study. Brain 2005; 128: 906-17.
55. Walker PM, Ben Salem D, Lalande A, Giroud M, Brunotte F. Time course of NAA T2 and ADC(w) in ischaemic stroke patients: 1HMRS imaging and diffusion-weighted MRI. J Neurol Sci 2004; 220: 23-8.
56. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, et al. Validation of the International Restless Legs Syndrome Study group rating scale for restless legs syndrome. Sleep Med 2003; 4: 121-32.
57. Walters AS, Ondo WG, Zhu W, Le W. Does the endogenous opiate system play a role in the restless legs syndrome? A pilot post-mortem study. J Neurol Sci 2009; 279: 62-5.
58. Winkelmann J, Prager M, Lieb R, Pfister H, Spiegel B, Wittchen HU, et al. "Anxietas tibiarum". Depression and anxiety disordersin patients with restless legs syndrome. J Neurol 2005; 252: 67-71.
59. Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001; 20: 45-57.